HolmbergL, AndersonH.HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomised comparison: trial stopped. Lancet2004;363(9407): 453–5
2.
LoprinziCL, KuglerJ, SloanJ, MailliardJ, BartonDVenlaxafine in management of hot flushes in survivors of breast cancer; a randomised controlled trial. Lancet2000; 356(9247);2059–63
3.
LoprinziCL, SloanJA, PerezEAPhase III evaluation of fluoxetin for treatment of hot flushes. J Clin Oncol2002;20(6):1578–83
4.
SandbergM.Letter to the editor. Acupunct Med2006;24(2):95–7.
5.
WyonY, LindgrenR, LundebergT, HammarM.Effects of acupuncture on climacteric vasomotor symptoms, Quality of Life and urinary excretion of neuropeptides among postmenopausal women. Menopause1995;2(1):3–12
6.
WyonY, WijmaK, NedstrandE, HammarM.A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Climacteric2004;7(2):153–64
7.
NedstrandE, WijmaK, WyonY, HammarM.Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric2005;8(3):243–50
8.
StreitbergerK, KleinhenzJ.Introducing a placebo needle into acupuncture research. Lancet1998;352(9125):364–5
9.
FreedmanR, WoodwardS.Behavioral treatment of menopausal hot flushes: Evaluation by ambulatory monitoring. Am J Obstet Gynecol1992;167(2):436–9
10.
MacLennanA, LesterS, MooreV.Oral estrogen replacement therapies versus placebo for hot flushes. The Cochrane Database Syst Rev2001;(1):CD002978
11.
FreedmanRR. Biochemical, metabolic, and vascular mechanisms in menopausal hot flushes. Fertil Steril1998; 70(2):322–7.
12.
WyonY, SpetzAC, TheodorssonE, HammarM.Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women. Menopause2000;7(1):25–30.
